Tickers

1. Composite Trajectory Verdict

Given POWL's engineered-to-order model with percentage-of-completion accounting, the income statement and cash flow statement carry the most weight because they reflect project execution, margin realization, and the conversion of backlog into cash; the balance sheet is important primarily as a measure of liquidity and leverage to sustain operations.

Composite Trajectory: Improving

Revenue, gross profit, operating income, and net income have grown in each of the last three fiscal years and continued to rise in the most recent quarter and nine-month period. Gross margin expanded from 21% in FY2023 to 29% in FY2025 and held near 30% in the first nine months of FY2026. Operating cash flow rebounded from a FY2024 dip to $167.9 million in FY2025 and surged to $195.0 million in the first nine months of FY2026. The balance sheet strengthened with cash rising to $633.6 million, equity increasing to $756.2 million, and zero borrowings on the revolver. Backlog nearly doubled to $2.4 billion, supporting forward visibility.

2. Red Flags

• Operating cash flow fell 40% year-over-year in FY2024 to $108.7 million due to a $34.7 million net cash outflow from contract assets and liabilities, before recovering to $167.9 million in FY2025 (10-K 2025-09-30, Consolidated Statements of Cash Flows).
• Accounts receivable grew 67% in nine months to $362.4 million at June 30, 2026 from $217.1 million at September 30, 2025, outpacing the 27% revenue increase over the same span (10-Q 2026-06-30, Condensed Consolidated Balance Sheets).
• Contract liabilities increased 56% to $466.4 million at June 30, 2026 from $297.9 million at September 30, 2025, pushing the net contract liability to -$350.4 million from -$161.3 million, reflecting heavy advance billings that must be executed (10-Q 2026-06-30, Note D Revenue).
• Cash payments for shares withheld for employee tax withholding rose sharply to $14.7 million in the first nine months of FY2026 from $12.0 million in the prior year period, driven by share price appreciation (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows).
• The company discloses probable liquidated damages exposure of $3.7 million (up to $4.3 million possible) with $3.4 million already recorded as a revenue reduction as of September 30, 2025 (10-K 2025-09-30, Note H Liquidated Damages).
• Research and development expense as a percentage of revenue increased to approximately 1.4% annualized in the first nine months of FY2026 from 1.0% in FY2025 (10-Q 2026-06-30, Condensed Consolidated Statements of Operations; 10-K 2025-09-30, Consolidated Statements of Operations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Revenue grew 9% to $1.104 billion in FY2025 from $1.012 billion in FY2024 and rose a further 7% to $859.5 million in the first nine months of FY2026 versus $806.3 million in the prior year period (10-K 2025-09-30, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Consolidated Statements of Operations). Gross margin expanded from 27% in FY2024 to 29% in FY2025 and reached 30% in the first nine months of FY2026 (10-K 2025-09-30, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Consolidated Statements of Operations). Net income increased 21% to $180.7 million in FY2025 and 8% to $139.4 million in the first nine months of FY2026 (10-K 2025-09-30, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Consolidated Statements of Operations). Diluted EPS rose from $12.29 in FY2024 to $14.86 in FY2025 and from $3.54 to $3.81 over the comparable nine-month periods (10-K 2025-09-30, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Operating cash flow rebounded to $167.9 million in FY2025 from $108.7 million in FY2024 and jumped to $195.0 million in the first nine months of FY2026 versus $106.9 million in the prior year period (10-K 2025-09-30, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows). The nine-month surge was driven by higher earnings and a $188.8 million positive swing in contract assets and liabilities (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows). Cash and equivalents grew to $633.6 million at June 30, 2026 from $450.7 million at September 30, 2025 and $315.3 million at September 30, 2024 (10-Q 2026-06-30, Condensed Consolidated Balance Sheets; 10-K 2025-09-30, Consolidated Balance Sheets). Investing activities turned positive at $14.5 million in the first nine months of FY2026 due to short-term investment maturities, while financing outflows remained stable at $24.5 million (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total assets increased 19% to $1.109 billion at September 30, 2025 from $928.2 million a year earlier and rose a further 27% to $1.407 billion at June 30, 2026 (10-K 2025-09-30, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets). Stockholders' equity grew 33% to $640.8 million at September 30, 2025 and 18% to $756.2 million at June 30, 2026 (10-K 2025-09-30, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets). The company held no borrowings on its $150 million revolver at either date, with letters of credit outstanding at $77.5 million and $103.9 million respectively (10-K 2025-09-30, MD&A Liquidity; 10-Q 2026-06-30, MD&A Liquidity). The current ratio improved from 1.8x at September 30, 2024 to 2.1x at September 30, 2025 and stood at 2.0x at June 30, 2026 (10-K 2025-09-30, MD&A Liquidity; 10-Q 2026-06-30, MD&A Liquidity).

6. Data Gaps

• June 30, 2025 balance sheet (for YoY quarterly balance sheet comparison) is not included in the provided 10-Q 2026-06-30 filing; the prior-period column shows September 30, 2025 only.
• Individual quarterly income statements for Q1 and Q2 FY2026 are not provided; only Q3 and nine-month aggregates appear in the 10-Q 2026-06-30.
• Full fiscal year 2026 results are not yet available (filings cover through June 30, 2026).
• Detailed commodity cost impacts (copper, aluminum, steel) on margins are discussed qualitatively but not quantified in the filings.
• Customer concentration metrics for the expanding data center backlog are not disclosed.